AG

Arjun G Nair

Active Director Director DIN 11318928
DIN 11318928 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Arjun G Nair

Data last updated:

Arjun G Nair is a Director at Badarinath Innate Formulations Private Limited (since 2025). The company operates in Pharma.

DIN 11318928
Primary Designation Director
Industry Pharma
First Appointment 26 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Sep 20252025Active

Directorship timeline

Open interactive timeline →
Badarinath Innate Formulations Private Limited
Premium access

Shareholding and investment profile for Arjun G Nair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arjun G Nair

Arjun G Nair currently holds 1 directorship: Badarinath Innate Formulations Private Limited (Director, since 26 Sep 2025).

Arjun G Nair was first appointed on 26 Sep 2025 as Director at Badarinath Innate Formulations Private Limited.

The current boards of Arjun G Nair's companies include Chandramathy (Badarinath Innate Formulations Private Limited), Punnaliparambil Kumaran Nair Gangadharan (Badarinath Innate Formulations Private Limited), Rajan (Badarinath Innate Formulations Private Limited), Rajana (Badarinath Innate Formulations Private Limited), Sajana Punnaliparambil Rajan (Badarinath Innate Formulations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available